Transchem Limited has received in-principle approval from BSE Limited for the preferential issue of 6,15,00,000 warrants of Rs. 10 each. The approval, granted via a letter dated May 21, 2026, was communicated to the stock exchanges on May 22, 2026. With the necessary regulatory approvals secured, the company will now initiate steps to consummate the preferential issue.

Utilization of Proceeds

The company has previously disclosed that an estimated amount of ₹115 crore from the issue proceeds has been designated for General Corporate Purposes (GCP). This allocation is intended to meet the general corporate needs of the company while ensuring compliance with the SEBI ICDR Regulations. The indicative timeline for the utilization of these funds is set between 6 to 18 months.

Strategic Acquisitions

Proceeds related to Sr. No. 1 of the objects are proposed to be utilised for strategic acquisitions, directed solely towards the broking and allied financial services sector. Transchem stated that the target entities intended for these investments or acquisitions are expected to become subsidiaries of the company under Section 2(87) of the Companies Act, 2013, subject to the completion of transactions and necessary approvals.

Shareholder and Allottee Details

Regarding the allottees, the disclosure clarified that Bakkt Opco Holdings, LLC (Allottee 1) is owned and controlled by Bakkt, Inc., a company listed on the New York Stock Exchange (NYSE: BKKT). Consequently, the company noted that it is not necessary to identify and verify the identity of any shareholder or beneficial owner of this allottee as per the SEBI Circular CIR/MIRSD/2/2013 dated January 24, 2013.

Transchem Limited filed a newspaper advertisement on May 07, 2026 with BSE Limited, confirming the publication of its audited financial results for the quarter and year ended March 31, 2026, in Financial Express (English) and Mumbai Lakshadeep (Marathi), pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing follows the outcome of the Board meeting reported on May 05, 2026 under Regulations 30 and 33 of the SEBI Listing Regulations. The company's audited results, along with a Quick Response (QR) code and details of the webpage where the results are accessible, were included in the newspaper advertisement. The results are also available on the company's website at www.transchem.net .

Financial Performance

The Board of Directors reviewed and approved the audited financial results at their meeting held on May 05, 2026. The company reported a net profit of ₹208.32 lakh for the fourth quarter, compared to ₹72.98 lakh in the corresponding period of the previous year. For the full fiscal year, the net profit stood at ₹429.51 lakh, a decrease from ₹522.59 lakh in the prior year. The total income for the year ended March 31, 2026, was ₹926.08 lakh, down from ₹1,116.29 lakh in the previous year. The company recorded no revenue from operations during the current year, while other income of ₹926.08 lakh contributed entirely to total earnings. The statutory auditors, M/s. Mathur & Co., Chartered Accountants, issued an unmodified opinion on the audited financial results, confirming compliance with Indian Accounting Standards and SEBI Listing Regulations.

The following table summarizes the key financial metrics from the published extract for the quarter and year ended March 31, 2026:

Assets and Liabilities

As of March 31, 2026, the company's total assets stood at ₹8,773.08 lakh, an increase from ₹7,972.56 lakh in the previous year. Cash and cash equivalents constituted a major portion of current assets, amounting to ₹4,242.91 lakh, up from ₹4,234.03 lakh. The equity share capital remained unchanged at ₹1,224.00 lakh, while other equity increased to ₹7,133.72 lakh from ₹6,707.54 lakh. Total equity stood at ₹8,357.72 lakh as against ₹7,931.54 lakh in the prior year.

Cash Flow Summary

The statement of cash flows for the year ended March 31, 2026, reflects a net decrease in cash from operating activities. Net cash used in operations stood at ₹156.59 lakh, compared to net cash generated of ₹3,600.03 lakh in the previous year. Cash flows from investing activities generated ₹165.47 lakh, driven primarily by proceeds from the sale of property, plant and equipment of ₹160.00 lakh. There were no financing activities during the year. The net increase in cash and cash equivalents for the year was ₹8.88 lakh, with closing cash and cash equivalents at ₹4,242.91 lakh.

Board Decisions and Auditor Appointments

Pursuant to Regulation 30 of the SEBI Listing Regulations, the Board approved the re-appointment of M/s. L. T. Jadav & Co., Chartered Accountants (FRN: 118218W), as Internal Auditors of the company under Section 138 of the Companies Act, 2013, with effect from May 05, 2026. The re-appointment covers the financial year 2026-2027, on such terms and conditions as may be mutually agreed between the company and the internal auditors.

The company also noted that the trading window would re-open 48 hours after the announcement of the results, and the extracts of the results will be published in newspapers as required under Regulation 47 of the SEBI Listing Regulations.

Warrant Issuance Update

The shareholders of Transchem Limited, at the Extraordinary General Meeting held on December 20, 2025, approved the issuance of up to 6,15,00,000 (Six Crores Fifteen Lakhs) warrants on a preferential basis, at an issue price of ₹75 per warrant, in accordance with the Companies Act, 2013 and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The company has made an application to BSE Limited for obtaining in-principle approval for the proposed allotment of warrants, which was awaited as on the date of the results. As at March 31, 2026, no warrants have been allotted, and accordingly, there is no impact of the proposed issue on the financial results for the quarter and year ended March 31, 2026.